Logotype for Sacyr S.A.

Sacyr (SCYR) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sacyr S.A.

Q3 2025 earnings summary

7 Nov, 2025

Executive summary

  • Revenue increased 5% year-over-year to €3.412 billion, with net profit excluding divestments up 81% to €134 million, driven by the concession model and new project wins.

  • EBITDA rose 7.4% to €1.018 billion, with 92% generated from concessions, reflecting a resilient, recurring cash flow profile.

  • Four new concession projects were awarded in Italy, Chile, and Paraguay, expanding the international portfolio.

  • Achieved Investment Grade rating from Morningstar DBRS, enhancing access to diversified and lower-cost financing.

  • Sale of three Colombian assets for $1.6 billion, 12% above internal valuation, with all approvals received and funds to be collected in November.

Financial highlights

  • Operating cash flow rose 11% to €890 million, with an EBITDA-to-cash conversion margin of 88%.

  • Net profit, excluding divestments, reached €134 million; after a €72 million one-off provision from the Colombia sale, final net profit was €62 million.

  • EBITDA margin improved to 30% from 29% year-over-year.

  • Net debt reduced to €6.489 billion from €6.891 billion at December 2024.

  • Market capitalization increased 14.6% to €2.84 billion, with a 9.5% rise in share price year-over-year.

Outlook and guidance

  • Strategic plan targets continued growth in core markets and expansion in North America, Australia, and large-scale projects.

  • Concession asset valuation updated to €4 billion, with a goal of €5.1 billion by 2027.

  • Operating cash flow for the year expected to reach about €1.3 billion, similar to the prior year.

  • Dividend expected to increase year-on-year, in line with the strategic plan.

  • Proceeds from Colombian asset sales in November will further reduce net recourse debt.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more